Stockfacts
Use CasesDocsPricing
Log inSign up free
OverviewFinancialsTrendsTranscriptsOptionsInstitutionsInsidersCorporate ActionsSEC Filings
Stockfacts

EOD US-equity data for investors and AI agents

Data is end-of-day, not real-time, and not investment advice

Use CasesDashboard

LRMR

Larimar Therapeutics, Inc.

CIK 0001374690 · Nasdaq

NasdaqHealth CarePharmaceutical Preparations
$4.13
↑ 0.52 (14.40%)
as of Jul 9, 2026
End-of-day close, not real-time intraday
Live price (Google Finance) ↗
Overall read: NeutralOverall score · based on 4/4 lenses
FundamentalsOwnershipTechnicalsOptions

Bullish: Ownership, Options; Risks: Fundamentals

Key stats

Market Cap
$429.04M
P/E Ratio
-2.58
EPS
Not covered
Dividend Yield
Not covered
52W Position
38%
Beta
1.73

Valuation multiples

Fwd P/E
Not covered
PEG
Not covered
P/B
2.71
P/S
Not covered
EV/Revenue
Not covered
ROE
-105.0%
Valuation data covers 8,503/9,463 US-listed stocks (89.9%).

Price · 1Y

251 trading days

End-of-day close, not real-time intraday

52-Week RangePosition 38%
$2.71$6.42

Latest Financials

2025-12-31 FY
Revenue
–
Net Income
-$165.67M
Total Assets
$145.84M
Free Cash Flow
-$113.29M

Recent news